Clintara, a company that works with pharmaceutical companies and clinical research organizations to optimize outcomes of Central Nervous System (CNS) clinical studies, said this week it has hired two new VP’s for executive jobs in Chicago.
Dr. Cara Pendergrass and Philip Rauh have been hired to be Clintara’s Vice President of Clinical Operations and Vice President, Client Services.
Pendergrass will manage a clinical team which includes more than 35 CNS clinicians in the Americas, MENA and APAC regions, while Rauh will focus on implementing the delivery of the Clintara platform to clients (including data collection, analysis and reporting).
“Philip’s extensive analytical experience with top-tier institutions in the financial services industry enhances our ability to collect, analyze and report on key data, in study,” said Bower. “His experience delivering long-term value for clients in a highly regulated industry will enable us to take a more proactive and quantitative approach to data collection, analyses and overall platform delivery for our clients and partners.”
Dr. Pendergrass will utilize her clinical and industry experience to enhance our internal clinical expertise and to leverage key clinical relationships with individual thought leaders specific to indications and institutional partners, like Massachusetts General Hospital, Keio Hospital in Tokyo, Cedars Sinai, Universidad Favaloro in Buenos Aires, and Klinikum der Universität München in Munich” said Clintara President, Colin Bower. “Cara will ensure that we effectively integrate these clinical assets with our new platform to continue to offer top clinical data analyses - mid study and real time - through an integrated and automated surveillance system designed to optimize clinical study results.”